• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体类抗雄激素药物康士得长期治疗对良性前列腺增生患者内分泌系统的影响。

Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.

作者信息

Eri L M, Haug E, Tveter K J

机构信息

Department of Surgery, Ullevaal University Hospital, Oslo, Norway.

出版信息

Br J Urol. 1995 Mar;75(3):335-40. doi: 10.1111/j.1464-410x.1995.tb07345.x.

DOI:10.1111/j.1464-410x.1995.tb07345.x
PMID:7537602
Abstract

OBJECTIVE

To study the hormonal changes resulting from long-term use of the non-steroidal anti-androgen Casodex.

PATIENTS AND METHODS

A randomized, placebo-controlled study was carried out on 27 patients with benign prostatic hyperplasia (BPH). Fourteen patients received Casodex 50 mg daily for 24 weeks and 13 received a placebo. The patients were followed up for a further 24-week period.

RESULTS

Serum concentrations of luteinizing hormone (LH) increased by an average of 40% while follicle-stimulating hormone (FSH) remained unchanged. Testosterone increased by 35%, oestradiol by 29% and oestrone by 23%; all changes were statistically significant. Levels of androstenedione and dihydrotestosterone increased by 11% and 15%, respectively, but these increases did not reach statistical significance. A non-significant increase was also observed for sex hormone-binding globulin. The hormonal changes were reversible upon discontinuation of therapy. Prolactin and dehydroepiandrosterone-sulphate levels did not change.

CONCLUSION

This study indicates that Casodex, due to competitive inhibition of central androgen receptors, increases LH secretion, thus causing increased production and increased metabolism of testosterone.

摘要

目的

研究长期使用非甾体类抗雄激素药物康士得所导致的激素变化。

患者与方法

对27例良性前列腺增生(BPH)患者进行了一项随机、安慰剂对照研究。14例患者每日服用50毫克康士得,持续24周,13例患者服用安慰剂。患者随后又接受了24周的随访。

结果

促黄体生成素(LH)的血清浓度平均升高了40%,而促卵泡生成素(FSH)保持不变。睾酮升高了35%,雌二醇升高了29%,雌酮升高了23%;所有变化均具有统计学意义。雄烯二酮和双氢睾酮的水平分别升高了11%和15%,但这些升高未达到统计学意义。性激素结合球蛋白也有不显著的升高。停药后激素变化是可逆的。催乳素和硫酸脱氢表雄酮水平未发生变化。

结论

本研究表明,由于康士得对中枢雄激素受体的竞争性抑制作用,它会增加LH的分泌,从而导致睾酮生成增加和代谢加快。

相似文献

1
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.非甾体类抗雄激素药物康士得长期治疗对良性前列腺增生患者内分泌系统的影响。
Br J Urol. 1995 Mar;75(3):335-40. doi: 10.1111/j.1464-410x.1995.tb07345.x.
2
Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer.新型非甾体抗雄激素药物康士得治疗前列腺癌期间的内分泌情况
Clin Endocrinol (Oxf). 1994 Oct;41(4):525-30. doi: 10.1111/j.1365-2265.1994.tb02585.x.
3
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.非甾体类抗雄激素药物康士得对良性前列腺增生患者脂蛋白、纤维蛋白原和纤溶酶原激活物抑制剂的影响。
Eur Urol. 1995;27(4):274-9. doi: 10.1159/000475180.
4
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.
Scand J Clin Lab Invest. 1996 Jul;56(4):319-25. doi: 10.3109/00365519609090583.
5
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.一项关于抗雄激素药物康士得治疗良性前列腺增生患者的前瞻性、安慰剂对照研究。
J Urol. 1993 Jul;150(1):90-4. doi: 10.1016/s0022-5347(17)35406-x.
6
New alternative treatment in hirsutism: bicalutamide 25 mg/day.多毛症的新型替代疗法:比卡鲁胺,每日25毫克。
Gynecol Endocrinol. 2002 Feb;16(1):63-6.
7
Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results.康士得(ICI 176,334),一种新型非甾体类抗雄激素药物。早期临床结果。
Horm Res. 1989;32 Suppl 1:77-81. doi: 10.1159/000181316.
8
Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat.
Acta Endocrinol (Copenh). 1991 Nov;125(5):547-55. doi: 10.1530/acta.0.1250547.
9
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia.抗雄激素药物康士得治疗良性前列腺增生的安全性、副作用及患者接受度
Eur Urol. 1994;26(3):219-26. doi: 10.1159/000475384.
10
Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.月经稀发青春期女孩的性激素谱及口服避孕药的影响。
Fertil Steril. 1984 Jun;41(6):888-93. doi: 10.1016/s0015-0282(16)47903-3.

引用本文的文献

1
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy.极高 PSA 水平转移性前列腺癌的治疗策略:重新考虑传统治疗的价值。
Asian J Androl. 2018 Sep-Oct;20(5):432-437. doi: 10.4103/aja.aja_24_18.
2
Neoadjuvant Enzalutamide Prior to Prostatectomy.前列腺切除术前新辅助恩杂鲁胺治疗
Clin Cancer Res. 2017 May 1;23(9):2169-2176. doi: 10.1158/1078-0432.CCR-16-1357. Epub 2016 Nov 9.
3
Letter to the Editor regarding "Testotoxicosis: Report of Two Cases, One with a Novel Mutation in Luteinizing Hormone/Choriogonadotropin Receptor Gene".
致编辑的信:关于“睾丸中毒症:两例报告,其中一例促黄体生成素/绒毛膜促性腺激素受体基因存在新突变”
J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):355. doi: 10.4274/jcrpe.2461.
4
A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide.一项比较抗雄激素单药疗法疗效的随机对照试验:氟他胺与比卡鲁胺对比
Horm Cancer. 2015 Aug;6(4):161-7. doi: 10.1007/s12672-015-0226-1. Epub 2015 May 30.
5
Urinary incontinence in the elderly. Causes and treatment options.
Drugs Aging. 1998 May;12(5):349-60. doi: 10.2165/00002512-199812050-00002.